| Studying noncollapsibility of the odds ratio with marginal structural and logistic regression models M Pang, JS Kaufman, RW Platt Statistical methods in medical research 25 (5), 1925-1937, 2016 | 100 | 2016 |
| Can we train machine learning methods to outperform the high-dimensional propensity score algorithm? ME Karim, M Pang, RW Platt Epidemiology 29 (2), 191-198, 2018 | 45 | 2018 |
| Confounding, effect modification and the odds ratio: common misinterpretations I Shrier, M Pang Journal of clinical epidemiology 68 (4), 470, 2015 | 39 | 2015 |
| Targeted maximum likelihood estimation for pharmacoepidemiologic research M Pang, T Schuster, KB Filion, M Eberg, RW Platt Epidemiology 27 (4), 570-577, 2016 | 29 | 2016 |
| Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort … M Durand, ME Schnitzer, M Pang, G Carney, S Eltonsy, KB Filion, ... Canadian Medical Association Open Access Journal 8 (4), E877-E886, 2020 | 22 | 2020 |
| Effect estimation in point-exposure studies with binary outcomes and high-dimensional covariate data–a comparison of targeted maximum likelihood estimation and inverse … M Pang, T Schuster, KB Filion, ME Schnitzer, M Eberg, RW Platt The international journal of biostatistics 12 (2), 20150034, 2016 | 19 | 2016 |
| On the role of marginal confounder prevalence–implications for the high‐dimensional propensity score algorithm T Schuster, M Pang, RW Platt Pharmacoepidemiology and drug safety 24 (9), 1004-1007, 2015 | 17 | 2015 |
| Flexible extension of the accelerated failure time model to account for nonlinear and time-dependent effects of covariates on the hazard M Pang, RW Platt, T Schuster, M Abrahamowicz Statistical Methods in Medical Research 30 (11), 2526-2542, 2021 | 14 | 2021 |
| Spline‐based accelerated failure time model M Pang, RW Platt, T Schuster, M Abrahamowicz Statistics in medicine 40 (2), 481-497, 2021 | 11 | 2021 |
| Effectiveness and safety among direct oral anticoagulants in nonvalvular atrial fibrillation: A multi‐database cohort study with meta‐analysis M Durand, ME Schnitzer, M Pang, G Carney, S Eltonsy, KB Filion, ... British Journal of Clinical Pharmacology 87 (6), 2589-2601, 2021 | 10 | 2021 |
| Psychometric properties of the Alzheimer’s Disease Cooperative Study–Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the … M Potashman, M Pang, M Tahir, S Shahraz, S Dichter, R Perneczky, ... BMC geriatrics 23 (1), 124, 2023 | 9 | 2023 |
| Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: an instrumental variable meta‐analysis M Pang, L Zhu, A Gabelle, AR Gafson, RW Platt, JE Galvin, ... Alzheimer's & Dementia 19 (4), 1292-1299, 2023 | 7 | 2023 |
| Graphic report of the results from propensity score method analyses I Shrier, M Pang, RW Platt Journal of clinical epidemiology 88, 154-159, 2017 | 7 | 2017 |
| Mixing of confounding and non-collapsibility: a notable deficiency of the odds ratio M Pang, JS Kaufman, RW Platt American Journal of Cardiology 111 (2), 302-303, 2013 | 7 | 2013 |
| Confounding of incidence density ratio in case-control studies S Greenland Epidemiology 24 (4), 624-625, 2013 | 4 | 2013 |
| Evaluating hybrid controls methodology in early‐phase oncology trials: A simulation study based on the MORPHEUS‐UC trial G Wang, M Poulin‐Costello, H Pang, J Zhu, HJ Helms, I Reyes‐Rivera, ... Pharmaceutical Statistics 23 (1), 31-45, 2024 | 3 | 2024 |
| “Translating” All-Cause Mortality Rate Ratios or Hazard Ratios to Age-, Longevity-, and Probability-Based Measures M Pang, JA Hanley American Journal of Epidemiology 190 (12), 2664-2670, 2021 | 3 | 2021 |
| Confounding of incidence density ratio in case-control studies M Pang, T Schuster Epidemiology 24 (4), 625-627, 2013 | 3 | 2013 |
| Precision medicine analysis of heterogeneity in individual‐level treatment response to amyloid beta removal in early Alzheimer's disease M Pang, A Gabelle, P Saha‐Chaudhuri, W Huijbers, A Gafson, ... Alzheimer's & Dementia 20 (2), 1102-1111, 2024 | 2 | 2024 |
| Bootstrapping the Cross-Validation Estimate B Cai, F Pellegrini, M Pang, C de Moor, C Shen, V Charu, L Tian arXiv preprint arXiv:2307.00260, 2023 | 2 | 2023 |
